198 related articles for article (PubMed ID: 24861746)
1. Quantitation of P450 3A4 endogenous biomarker - 4β-hydroxycholesterol - in human plasma using LC/ESI-MS/MS.
Huang MQ; Lin W; Wang W; Zhang W; Lin ZJ; Weng N
Biomed Chromatogr; 2014 Jun; 28(6):794-801. PubMed ID: 24861746
[TBL] [Abstract][Full Text] [Related]
2. LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume.
Xu Y; Yuan Y; Smith L; Edom R; Weng N; Mamidi R; Silva J; Evans DC; Lim HK
J Pharm Biomed Anal; 2013 Nov; 85():145-54. PubMed ID: 23948760
[TBL] [Abstract][Full Text] [Related]
3. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.
Suzuki Y; Oda A; Negami J; Toyama D; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
J Lipid Res; 2022 Mar; 63(3):100184. PubMed ID: 35181316
[TBL] [Abstract][Full Text] [Related]
4. Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
Goodenough AK; Onorato JM; Ouyang Z; Chang S; Rodrigues AD; Kasichayanula S; Huang SP; Turley W; Burrell R; Bifano M; Jemal M; LaCreta F; Tymiak A; Wang-Iverson D
Chem Res Toxicol; 2011 Sep; 24(9):1575-85. PubMed ID: 21728364
[TBL] [Abstract][Full Text] [Related]
5. Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals.
Hasan M; Siegmund W; Oswald S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():193-199. PubMed ID: 27565568
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
[TBL] [Abstract][Full Text] [Related]
7. Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
Aubry AF; Dean B; Diczfalusy U; Goodenough A; Iffland A; McLeod J; Weng N; Yang Z
AAPS J; 2016 Sep; 18(5):1056-1066. PubMed ID: 27350147
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of 4β- and 4α‑hydroxycholesterol in human plasma and serum by UHPLC/ESI-HR-MS.
Hautajärvi H; Hukkanen J; Turpeinen M; Mattila S; Tolonen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():179-186. PubMed ID: 30340067
[TBL] [Abstract][Full Text] [Related]
9. A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma.
van de Merbel NC; Bronsema KJ; van Hout MW; Nilsson R; Sillén H
J Pharm Biomed Anal; 2011 Jul; 55(5):1089-95. PubMed ID: 21507593
[TBL] [Abstract][Full Text] [Related]
10. Use of 4β-hydroxycholesterol in animal and human plasma samples as a biomarker for CYP3A induction.
Xue YJ; Hoffmann M; Tong Z; Wu XI; Vallejo M; Melo B; Ye Y; Thomas M; Liu Y; Weiss D; Surapaneni S
Bioanalysis; 2016 Feb; 8(3):215-28. PubMed ID: 26805594
[TBL] [Abstract][Full Text] [Related]
11. Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.
Mao J; Martin I; McLeod J; Nolan G; van Horn R; Vourvahis M; Lin YS
Drug Metab Rev; 2017 Feb; 49(1):18-34. PubMed ID: 27718639
[TBL] [Abstract][Full Text] [Related]
12. Method development for the determination of 24S-hydroxycholesterol in human plasma without derivatization by high-performance liquid chromatography with tandem mass spectrometry in atmospheric pressure chemical ionization mode.
Sugimoto H; Kakehi M; Satomi Y; Kamiguchi H; Jinno F
J Sep Sci; 2015 Oct; 38(20):3516-24. PubMed ID: 26249017
[TBL] [Abstract][Full Text] [Related]
13. 4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
Li K; Zhao S; Zhang L; Wu X; Shu P; Wang Y; Feng H; Gu Z; Han Hsu H
Drug Metab Dispos; 2014 May; 42(5):839-43. PubMed ID: 24595680
[TBL] [Abstract][Full Text] [Related]
14. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS.
Honda A; Yamashita K; Hara T; Ikegami T; Miyazaki T; Shirai M; Xu G; Numazawa M; Matsuzaki Y
J Lipid Res; 2009 Feb; 50(2):350-7. PubMed ID: 18815436
[TBL] [Abstract][Full Text] [Related]
15. Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry.
Pataj Z; Liebisch G; Schmitz G; Matysik S
J Chromatogr A; 2016 Mar; 1439():82-88. PubMed ID: 26607314
[TBL] [Abstract][Full Text] [Related]
16. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
Helmschrodt C; Becker S; Schröter J; Hecht M; Aust G; Thiery J; Ceglarek U
Clin Chim Acta; 2013 Oct; 425():3-8. PubMed ID: 23827692
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
Jemal M; Schuster A; Whigan DB
Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
[TBL] [Abstract][Full Text] [Related]
18. Bioanalysis of tolvaptan, a novel AVP-V2 receptor antagonist in human plasma by a novel LC-ESI-MS/MS method: a pharmacokinetic application in healthy South Indian male subjects.
Derangula VR; Pilli NR; Bhukya BR; Pulipati CR; Adireddy V; Ponneri V
Biomed Chromatogr; 2014 Mar; 28(3):332-40. PubMed ID: 23982910
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of UHPLC-ESI-MS/MS method for the determination of selected cardiovascular drugs, polyphenols and their metabolites in human urine.
Magiera S; Baranowska I; Kusa J
Talanta; 2012 Jan; 89():47-56. PubMed ID: 22284458
[TBL] [Abstract][Full Text] [Related]
20. Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical herb-drug interaction study.
Wang XD; Li JL; Lu Y; Chen X; Huang M; Chowbay B; Zhou SF
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):534-44. PubMed ID: 17339138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
